Baucus and Grassley are also looking for a personal briefing on the matter by Eschenbach.
This is not the first time that von Eschenbach has made this proposal.
FORBES: Importance of a Drug's "Risk-Benefit" Profile Eludes Former FDA Commissioner
In a prepared statement, FDA Acting Commissioner Andrew C. von Eschenbach, M.
Andrew von Eschenbach was grilled by Democrats in Congress at his nomination hearing for commissioner of the Food and Drugs Administration .
Andrew von Eschenbach, a former commissioner of the FDA and before that director of the National Cancer Institute, currently president of Samaritan Health Initiatives.
While we ate and Lang and Eschenbach gossiped a little about the classical-music world, a large television tuned to CCTV murmured on the wall.
It is being brought forth by Dr. Andrew von Eschenbach, a former commissioner of the FDA and Dr. Tomas Philipson of the University of Chicago.
FORBES: Importance of a Drug's "Risk-Benefit" Profile Eludes Former FDA Commissioner
That night, Lang Lang, his parents, a few guests, and Eschenbach took a room at the Palm Springs club, tucked away in a posh apartment building, for dinner.
The FDA's most recent commissioner, Andrew von Eschenbach, understood this.
The previous FDA head, Andrew von Eschenbach, permitted self-styled whistleblowers to flout the agency's ethics rules by publicly contradicting agency policy and disparaging drugs and drug companies that they disliked.
"It appears that the new guidance on communicating drug safety information has not improved the FDA's ability to protect the American people in a timely manner, " the senators said in their letter to FDA Commissioner Dr. Andrew von Eschenbach.
应用推荐